期刊文献+

5-氟尿嘧啶诱导人大肠癌多药耐药细胞株及细胞凋亡的实验研究 被引量:6

5-Flourouracil-induced apoptosis in multi-drug resistance human colorectal cancer cell lines
下载PDF
导出
摘要 目的:研究5-氟尿嘧啶(5-FU)诱导LOVO细胞凋亡,探讨人大肠癌多药耐药机制。方法:用噻唑蓝(MTT)法、光镜及电镜、DNA凝胶电泳和原位DNA末端转移酶标记法,分别对耐药细胞株LOVO/5-FU细胞及敏感细胞株LOVO细胞进行5-FU诱导细胞凋亡的实验研究。结果:LOVO/5-FU细胞存活率明显高于LOVO细胞,光镜和电镜观察凋亡形态学改变,凋亡细胞DNA凝胶电泳可以出现梯形(ladder)凋亡带,LOVO细胞原位DNA末端转移酶标记阳性率高于LOVO/5-FU。结论:(1)5-FU诱导人大肠癌LOVO细胞凋亡,有明显的时间和剂量效应。(2)在相同条件下,耐药细胞株LOVO/5-FU与敏感细胞株LOVO相比,前者凋亡受到抑制。(3)细胞凋亡对研究大肠癌LOVO细胞多药耐药机制,克服化疗产生的多药耐药及逆转多药耐药具有重要的临床价值。 Objective To study 5-flourouracil(5-FU)-induced apoptosis of LOVO cells and explore the mechanism of multi-drug resistance in human colorectal cancer. Methods MTT assay, optical microscopy, electron microscopy, DNA agarose gel electrophoresis, and in situ DNA nick end-labeling were used to detect the apoptosis in the drug resistant LOVO/ 5-FU and sensitive LOVO cells. Results The survival rate of LOVO/5-FU cells was significantly higher than that of LOVO cells. The morphological changes of apoptotie cell in both cell lines were observed using both optical and electron microscopy. A ladder-like apoptofic band was shown by agarose gel electrophoresis. The positive rate of in situ DNA nick end-labeling in LOVO cells was higher than that in LOVO/5-FU cells. Conclusions (1) 5-FU induces the apoptosis of human colorectal cancer LOVO cells in a characteristic dose- and time-dependant manner. (2) The apoptosis in the drug resistant LOVO/5-FU cells was much less than that in sensitive LOVO cells under the same condition. (3) Apoptasis may play an important role in studying the mechanism of multi-drug resistance in human colorectal cancer LOVO cells and preventing the development of multi-drug resistance induced by chemotherapy as well as eliminating this multi-drug resistance.
出处 《实用医学杂志》 CAS 2006年第10期1106-1108,共3页 The Journal of Practical Medicine
基金 广东省科技攻关项目基金(编号:99B06703G) 广东省自然基金项目(编号:5301056)
关键词 结直肠肿瘤 氟尿嘧啶 抗药性 肿瘤 细胞凋亡 Colorectal neoplasms Fluomuracil Drug resistance, neoplasm Apoptosis
  • 相关文献

参考文献10

二级参考文献53

  • 1栾凤君,杨纯正.一株人红白血病多药耐药细胞系(K562/A02)的建立及其耐药特性...[J].中华肿瘤杂志,1993,15(2):101-103. 被引量:68
  • 2蔡学君,张学庸,樊代明.胃癌耐药细胞株耐药谱的体外实验[J].第四军医大学学报,1994,15(2):86-88. 被引量:13
  • 3卿三华,周锡庚,周正端,齐德林,姚明,梁立德.大剂量大容积5-氟脲嘧啶腹腔化疗治疗结直肠癌的实验和临床研究[J].中华肿瘤杂志,1996,18(2):92-92. 被引量:7
  • 4敖朝晖 卢圣栋.多聚酶链反应技术.现代分子生物学技术[M].北京:高等教育出版社,1993.408-408.
  • 5Furukawa T, Cuelife JS, Spartt WJ. A clinical pilot study combining surgary with intraoperative pelvic hypsthermochemotherapy to prevant the colon recurrence of rectal carcer. Anticancer Res 1993;13:287-291.
  • 6Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, Akigoshi T. Molecular detection of circulating solid carcinoma cell in the peripheral blood: the concept of early systemilc disease. Int J Cancer 1996,68:739-743.
  • 7Almquist KC, Loe DW, Hipfner DR, Mackie JE, Cole SP, Deeley RG. Characterization of the Mr 190 000 multidrug resistance protein (MRP) in drug- selected and transfected human tumor cell. Cancer Res 1995;55:102-110.
  • 8Peters PJ, Geuze HJ, van der Donk HA, Borst J. A new model for lethal hit delivery by cytotoxic T lymphocytes. Immunol Today 1990;11:28-32.
  • 9Gewirtz DA. Does bulk damage to DNA explain the cytostatic and cytotoxic effects of Topoisomerase II inhibition? Biochem Pharmacol 1991;42:2253-2258.
  • 10Sela S, Husain SR, Pearson JW, Longo DL, Rahman A. Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combinationwith monoclonal antibody or verapamil. J Natl Cancer Inst 1995;87:123-128.

共引文献17

同被引文献84

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部